Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Peptide Receptor Radionuclide Therapy in Patients With Advanced Progressive Medullary Thyroid Cancer: Efficacy, Safety, and Survival Predictors.

Qingxing Liu,Harshad R Kulkarni,Tianzhi Zhao,Christiane Schuchardt,Xiaoyuan Chen,Zhaohui Zhu,Jingjing Zhang,Richard P Baum

Clinical nuclear medicine（2023）

Cited 2|Views34
No score
Abstract
Peptide receptor radionuclide therapy was well tolerated and effective in patients with advanced, aggressive MTC. Bone metastasis was an independent adverse prognostic factor for OS.
More
Translated text
Key words
Lu-177,Y-90,medullary thyroid cancer,peptide receptor radionuclide therapy,safety,survival
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined